thetaOwl

MRVL

Marvell Technology, Inc.Close $279.70EOD only
Max Pain
$160.00
Next expiry Jun 18, 2026
Expected Move
±$30.78
11.0% from close
Price Gap
-119.70
Distance to max pain
IV Rank
93
High premium
P/C OI
1.10
Balanced positioning
Consensus
7.0/10
Bullish tilt
Published snapshot: Jun 12, 2026 close
End-of-day snapshot

This page reflects MRVL options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 12, 2026 close
MRVL AI Consensus Report
Analysis based on market close June 12, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.0

out of 10

7/10 because strong alignment across personas is countered by the 76-days-to-earnings uncertainty and spot being 9.7% from max pain ($255), which could trigger repositioning.

Where Perspectives Agree

All personas agree on a bullish pin near $260, supported by dealer long gamma, heavy call flow, and positive GEX, with upside targets to $300-310.

Where They Diverge

Theta's concern about elevated IV distorting premiums and max pin risk contradicts the directional/flow thesis that high IV offers opportunity, but this is a risk management nuance, not a fundamental conflict.

Top Trade
via directional

Buy 2026-07-17 $270/$300 call spread for $10.00 debit (max risk $10, max reward $20).

Key Risk

Break below $235 gamma flip triggers dealer hedging and accelerates downside to $230, invalidating the bullish pin thesis.

How to Use These Reports
This ai consensus reflects the market close on June 12, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.